 DERMADEX
|
GlaxoSmithKline Biopharma
|
| clobetasol |
Antieccematoso |
| cr.x 15 g | $22.302,70 | (01/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.921,08 AF $13.381,62 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $17.304,08 |
|
|
|
|
| cr.x 30 g | $43.738,02 | (01/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $17.495,21 AF $26.242,81 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $37.809,77 |
|
|
|
|
| ung.x 15 g | $21.136,04 | (01/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $8.454,42 AF $12.681,62 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $4.998,62 AF $16.137,42 |
|
|
|
|
| ung.x 30 g | $40.509,23 | (01/04/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
PAMI PLAN MEDICAMENTOS DE USO EVENTUAL |
| OS $16.203,69 AF $24.305,54 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $5.928,25 AF $34.580,98 |
|
|
|
|
| |
